Top Markets
Coin of the day
Jyong Biotech Ltd. Ordinary Shares Jyong Biotech Ltd. Ordinary Shares

Jyong Biotech Ltd. Ordinary Shares

MENS
Rang in aandelen #19258
Jyong Biotech Ltd. is a Taiwanese biotechnology enterprise dedicated to the... Jyong Biotech Ltd. is a Taiwanese biotechnology enterprise dedicated to the research, development, and market introduction of botanical therapeutics, specifically aimed at addressing diseases of the urinary system. Its operations are orchestrated through various subsidiary entities, including Health Ever Bio-Tech and Genvace. The company is actively advancing a robust pipeline of drug candidates, which notably features MCS-2, currently undergoing Phase III trials for benign prostatic hyperplasia (BPH); PCP, which is in Phase II development for prostate cancer; and IC, presently in pre-clinical stages.
Aandeelprijs
$2.22
Laatst gesynchroniseerd: 2026-08-25
Marktkapitalisatie
$168.64M
Verandering (1 dag)
-0.09%
Verandering (1 jaar)
-95.58%
Land
TW
Handel Jyong Biotech Ltd. Ordinary Shares (MENS)

Categorie

Dividendrendementgeschiedenis voor Jyong Biotech Ltd. Ordinary Shares (MENS)
Het dividendrendement (TTM) van Jyong Biotech Ltd. Ordinary Shares (aandelsymbool: MENS) per 2026 is: 0
Gemiddeld dividendrendement over de afgelopen 5 jaar: 0.00%
Dividendrendementgeschiedenis van Jyong Biotech Ltd. Ordinary Shares (MENS) van 2026 tot 2026
Dividendrendement aan het einde van elk jaar (TTM)
Jaar Dividendrendement Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Dividendrendementen (TTM) van vergelijkbare bedrijven of concurrenten
Bedrijf Dividendrendement Land
0.00%
US
0.00%
NL
0.00%
US
3.12%
AU
0.00%
CH